TRIENTINE Drug Patent Profile
✉ Email this page to a colleague
When do Trientine patents expire, and when can generic versions of Trientine launch?
Trientine is a drug marketed by Accord Hlthcare, Amneal, Chartwell Rx, Dr Reddys, Eci Pharms Llc, Hetero Labs Ltd Iii, Lupin, MSN, Navinta Llc, Ph Health, Rising, Watson Labs Teva, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in TRIENTINE is trientine hydrochloride. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trientine
A generic version of TRIENTINE was approved as trientine hydrochloride by NAVINTA LLC on January 16th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIENTINE?
- What are the global sales for TRIENTINE?
- What is Average Wholesale Price for TRIENTINE?
Summary for TRIENTINE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for TRIENTINE |
| DailyMed Link: | TRIENTINE at DailyMed |


